[Carbapenem-resistant Acinetobacter baumannii strains]
Tomasz Bogiel1, Joanna Kwiecińska-Piróg, Katarzyna Jachna-Sawicka
1Katedra i Zakład Mikrobiologii Collegium Medicum im. L. Rydygiera w Bydgoszczy Uniwersytet Mikolaja Kopernika w Toruniu.
Abstract:
A. baumannii rods are opportunistic pathogens responsible generally for nosocomial infections. Resistance to carbapenems, observed among them, is a serious threat due to ability to be transmitted between bacterial species. The aim of our study was to evaluate the frequency of isolation and susceptibility to antibiotics of resistant to imipenem and/or meropenem A. baumannii strains isolated between 2007 and 2009 from patients of University Hospital of dr A. Jurasz Collegium Medicum of L. Rydygier in Bydgoszcz Nicolaus Copernicus University in Toruń. Study shows increasing frequency of isolation that type of strains from 4 in 2007 to 95 in 2008 and 67 in 2009. Percentage of imipenem-resistant isolates raised to 27.6% in 2008 and 31.0% in 2009. Meropenem-resistant A. baumannii isolates frequency changed from 2.1% in 2007 to 31.2% and 34.6%, in 2008 and 2009, respectively. The majority of strains were obtained from patients of the Intensive Care Units and surgery clinics. Examined A. baumannii strains were generally isolated from bronchoalveolar lavage (25.3%) and wound (18.1%) or throat (12.0%) swabs samples. The isolates demonstrated full resistance to norfloxacin, ciprofloxacin, and chloramphenicol. Ampicillin/sulbactam (24.8%), tobramycin (8.1%) and colistin (1.5%) presented the highest in vitro activity against isolated strains.
Insights
Carbapenem-resistant Acinetobacter baumannii (CRAB) infections are increasing, particularly in hospital settings. Colistin and tobramycin showed the most promise against these resistant strains.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Acinetobacter baumannii is an opportunistic pathogen frequently causing nosocomial infections.
- Carbapenem resistance in A. baumannii poses a significant threat due to inter-species transmissibility.
Purpose of the Study:
- To evaluate the isolation frequency and antibiotic susceptibility of imipenem- and/or meropenem-resistant A. baumannii strains.
- To analyze trends in CRAB infections between 2007 and 2009 at a university hospital.
Main Methods:
- Retrospective analysis of A. baumannii isolates from 2007-2009.
- Antimicrobial susceptibility testing using standard microbiological methods.
- Data collection on patient demographics and sample sources.
Main Results:
- A significant increase in CRAB isolation frequency was observed, from 4 strains in 2007 to 95 in 2008 and 67 in 2009.
- Imipenem resistance rose to 27.6% in 2008 and 31.0% in 2009; meropenem resistance reached 31.2% and 34.6% in 2008 and 2009, respectively.
- Highest in vitro activity against CRAB was demonstrated by colistin (1.5% resistance), tobramycin (8.1% resistance), and ampicillin/sulbactam (24.8% resistance).
Conclusions:
- CRAB infections show a concerning increasing trend, predominantly in Intensive Care Units and surgical clinics.
- CRAB strains exhibit high resistance to common antibiotics like fluoroquinolones and chloramphenicol.
- Colistin and tobramycin remain the most effective therapeutic options against CRAB isolates in this study.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance

